Cargando…

Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination

Mass drug administration (MDA) is, and has been, the principal method for the control of the schistosome helminths. Using MDA only is unlikely to eliminate the infection in areas of high transmission and the implementation of other measures such as reduced water contact improved hygiene and sanitati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kura, Klodeta, Truscott, James E., Toor, Jaspreet, Anderson, Roy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550388/ https://www.ncbi.nlm.nih.gov/pubmed/31166956 http://dx.doi.org/10.1371/journal.pntd.0007349

Ejemplares similares

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
por: Kura, Klodeta, et al.
Publicado: (2020)

Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
por: Kura, Klodeta, et al.
Publicado: (2022)

Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration
por: Kura, Klodeta, et al.
Publicado: (2020)

Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment
por: Ayabina, Diepreye, et al.
Publicado: (2021)

Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission
por: Toor, Jaspreet, et al.
Publicado: (2019)

Human population movement can impede the elimination of soil-transmitted helminth transmission in regions with heterogeneity in mass drug administration coverage and transmission potential between villages: a metapopulation analysis
por: Vegvari, Carolin, et al.
Publicado: (2019)

What is the impact of acquired immunity on the transmission of schistosomiasis and the efficacy of current and planned mass drug administration programmes?
por: Kura, Klodeta, et al.
Publicado: (2021)

Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
por: Toor, Jaspreet, et al.
Publicado: (2020)

Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
por: Kura, Klodeta, et al.
Publicado: (2021)

The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni
por: Toor, Jaspreet, et al.
Publicado: (2018)

The past matters: estimating intrinsic hookworm transmission intensity in areas with past mass drug administration to control lymphatic filariasis
por: Werkman, Marleen, et al.
Publicado: (2017)

Developing a mathematical model for the evaluation of the potential impact of a partially efficacious vaccine on the transmission dynamics of Schistosoma mansoni in human communities
por: Stylianou, Andria, et al.
Publicado: (2017)

The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths
por: Anderson, Roy, et al.
Publicado: (2014)

Determinants of Schistosoma mansoni transmission in hotspots at the late stage of elimination in Egypt
por: Ghazy, Ramy Mohamed, et al.
Publicado: (2022)

The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission
por: Farrell, Sam H., et al.
Publicado: (2017)

Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?
por: Toor, Jaspreet, et al.
Publicado: (2018)

Proposed morbidity markers among Schistosoma mansoni patients
por: Shehab, Amel Youssef, et al.
Publicado: (2023)

How important is the spatial movement of people in attempts to eliminate the transmission of human helminth infections by mass drug administration?
por: Collyer, Benjamin S., et al.
Publicado: (2023)

Elimination of Schistosoma mansoni in infected mice by slow release of artemisone
por: Gold, Daniel, et al.
Publicado: (2017)

Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine?
por: Wilson, R. Alan, et al.
Publicado: (2008)

Defining stopping criteria for ending randomized clinical trials that investigate the interruption of transmission of soil-transmitted helminths employing mass drug administration
por: Werkman, Marleen, et al.
Publicado: (2018)

Toward Mass Drug Administration Stopping Criteria for Schistosoma mansoni Control Programs
por: Secor, W. Evan
Publicado: (2019)

Individual longitudinal compliance to neglected tropical disease mass drug administration programmes, a systematic review
por: Maddren, Rosie, et al.
Publicado: (2023)

SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection
por: King, Charles H., et al.
Publicado: (2020)

The observed relationship between the degree of parasite aggregation and the prevalence of infection within human host populations for soil-transmitted helminth and schistosome infections
por: Kura, Klodeta, et al.
Publicado: (2022)

Schistosoma mansoni infection after three years of mass drug administration in Sierra Leone
por: Sesay, Santigie, et al.
Publicado: (2014)

Multihost Transmission of Schistosoma mansoni in Senegal, 2015–2018
por: Catalano, Stefano, et al.
Publicado: (2020)

Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa
por: King, Charles H., et al.
Publicado: (2020)

Schistosoma mansoni Mass Drug Administration Regimens and Their Effect on Morbidity among Schoolchildren over a 5-Year Period—Kenya, 2010–2015
por: Sircar, Anita D., et al.
Publicado: (2018)

Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya
por: Abudho, Bernard O., et al.
Publicado: (2020)

Economic Evaluations of Mass Drug Administration: The Importance of Economies of Scale and Scope
por: Turner, Hugo C, et al.
Publicado: (2018)

Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration
por: Crellen, Thomas, et al.
Publicado: (2016)

Impact of Schistosoma mansoni on Malaria Transmission in Sub-Saharan Africa
por: Ndeffo Mbah, Martial L., et al.
Publicado: (2014)

Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo
por: Nigo, Maurice M., et al.
Publicado: (2021)

Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages
por: Arndts, Kathrin, et al.
Publicado: (2021)

Testing for soil-transmitted helminth transmission elimination: Analysing the impact of the sensitivity of different diagnostic tools
por: Werkman, Marleen, et al.
Publicado: (2018)

Cytosine methylation regulates oviposition in the pathogenic blood fluke Schistosoma mansoni
por: Geyer, Kathrin K., et al.
Publicado: (2011)

Should the Goal for the Treatment of Soil Transmitted Helminth (STH) Infections Be Changed from Morbidity Control in Children to Community-Wide Transmission Elimination?
por: Anderson, Roy M., et al.
Publicado: (2015)

Predicting the effects of climate change on Schistosoma mansoni transmission in eastern Africa
por: McCreesh, Nicky, et al.
Publicado: (2015)

Transmission of Schistosoma mansoni in Yachi areas, southwestern Ethiopia: new foci
por: Bekana, Teshome, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k0ljk4shfll4isk694t0vi7g4d